Two publications from the past week:

• Development of an optimized and generic cost-utility model for analyzing genome-guided treatment data | link
• Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Five publications from the past week:

• The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis | link
• Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access | link
• Medical costs of children admitted to the neonatal intensive care unit: The role and possible economic impact of WES in early diagnosis | link
• Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States | link
• Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Defining a Core Data Set for the Economic Evaluation of Precision Oncology | link
• Trio genome sequencing for developmental delay and pediatric heart conditions: A comparative microcost analysis | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication from the past week:

• Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Health economic evidence for the use of molecular biomarker tests in hematological malignancies: a systematic review | link
• Cost Efficacy of Rapid Whole Genome Sequencing in the Pediatric Intensive Care Unit | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Three publications from the past week:

• Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol | link
• Assessing women’s preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a mixed-methods design | link
• Economic evaluation in psychiatric pharmacogenomics: a systematic review | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision Oncology | link
• Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Developing new frameworks to value genomic information: accounting for complexity | link
• Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

A bumper crop of publications from the holiday period:

• Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases | link
• The complexity of diagnosing rare disease: An organizing framework for outcomes research and health economics based on real-world evidence | link
• Economic evaluations of exome and genome sequencing in pediatric genetics: considerations towards a consensus strategy | link
• Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients | link
• Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization | link
• The cost-effectiveness of genotyping versus sequencing for prenatal cystic fibrosis carrier screening | link
• Precision medicine testing in ovarian cancer: The growing inequity between patients with commercial vs medicaid insurance | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication from the past week:

• Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.